SPRY logo
ARS Pharmaceuticals, Inc.(SPRY)
Last print unknown agoAbout this dataData status
$4.23▲0.21 (5.22%)Stale · unknown old

SPRY Operating Expenses

$302.67MTTM · USD

Period ending:

SPRY FY Operating ExpensesUSD
SPRY FY Operating Expenses2018-12-31: $16.90M2019-12-31: $22.52M2020-12-31: $4.23M2021-12-31: $24.75M2022-12-31: $19.71M2023-12-31: $67.55M2024-12-31: $71.68M2025-12-31: $243.30M$243.30M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SPRY operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Ars Pharmaceuticals Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
243,303,000
71,675,000
67,550,000
19,712,000
24,747,000
4,234,000
22,521,000
16,900,000

Compare operating expenses

All SPRY financial metrics · SPRY stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.